5-[2-(2-hydroxy-phenyl)-oxazol-4-yl]-pentanoic acid | 847266-81-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 5-[2-(2-hydroxy-phenyl)-oxazol-4-yl]-pentanoic acid
• 英文别名: 5-[2-(2-Hydroxyphenyl)-1,3-oxazol-4-yl]pentanoic acid
• CAS: 847266-81-3
• 化学式: C₁₄H₁₅NO₄
• 分子量: 261.277
• InChiKey: YRBGBGQNKABFAM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  83.6
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• [EN] COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON LIKE PEPTIDE (GLP)-1 COMPOUND OR AN MELANOCORTIN 4 RECEPTOR (MC4) AGONIST PEPTIDE<br/>[FR] COMPOSES, PROCEDES ET PREPARATIONS DESTINES A L'APPORT ORAL D'UN COMPOSE PEPTIDIQUE DE TYPE GLUCAGON (GLP-1) OU D'UN PEPTIDE AGONISTE DU RECEPTEUR 4 DE MELANOCORTINE (MC4)
  申请人：LILLY CO ELI

  公开号：WO2005019184A1

  公开（公告）日：2005-03-03

  The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.

  本发明涉及用于口服给荷GLP-1化合物或MC4激动剂肽的新化合物、方法和配方。
• Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
  申请人：Herr Robert Jason

  公开号：US20080214448A1

  公开（公告）日：2008-09-04

  The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.

  本发明涉及一种新型化合物、方法和配方，用于口服给药GLP-1化合物或MC4激动剂肽。
• COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON-LIKE PEPTIDE (GLP-1) COMPOUND OR A MELANOCORTIN-4 RECEPTOR (MC4) AGONIST PEPTIDE
  申请人：HERR Robert Jason

  公开号：US20100120876A1

  公开（公告）日：2010-05-13

  The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.

  本发明涉及一种新型化合物、方法和配方，用于口服给药GLP-1化合物或MC4激动剂肽。
• COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON-LIKE PEPTIDE (GLP-1) COMPOUND OR A MELANOCORTIN-4 RECEPTOR (MIC4) AGONIST PEPTIDE
  申请人：Emisphere Technologies, Inc.

  公开号：US20140031287A1

  公开（公告）日：2014-01-30

  The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.

  本发明涉及新型化合物、方法和配方，用于口服给药GLP-1化合物或MC4激动剂肽。
• COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON LIKE PEPTIDE (GLP)-1 COMPOUND OR AN MELANOCORTIN 4 RECEPTOR (MC4) AGONIST PEPTIDE
  申请人：ELI LILLY AND COMPANY

  公开号：EP1658273A1

  公开（公告）日：2006-05-24